Neumora Therapeutics Inc (NMRA)

Jul 23, 2025

Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - The Manila Times

Jul 23, 2025

Jul 23, 2025

Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - GlobeNewswire Inc.

Jul 23, 2025

Jul 23, 2025

What drives Neumora Therapeutics Inc. stock priceUnmatched profit growth - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

What analysts say about Neumora Therapeutics Inc. stockMarket-leading profit generation - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Mizuho Lifts PT on Neumora Therapeutics (NMRA) to $5 from $4, Keeps Outperform Rating - MSN

Jul 23, 2025

Jul 23, 2025

Neumora Therapeutics Inc. Stock Analysis and ForecastUnmatched market gains - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

Is Neumora Therapeutics Inc. a good long term investmentTriple-digit profit margins - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What makes Neumora Therapeutics Inc. stock price move sharplyAI Powered Stock Call - Newser

Jul 22, 2025

Jul 22, 2025

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Jul 22, 2025

Jul 19, 2025

Neumora Therapeutics (NASDAQ:NMRA) Price Target Raised to $5.00 - Defense World

Jul 19, 2025

Jul 19, 2025

Neumora Therapeutics (NASDAQ:NMRA) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat

Jul 19, 2025

Jul 18, 2025

How Neumora Therapeutics Inc. stock reacts to Fed policy changesMarket Beating Strategy - Newser

Jul 18, 2025

Jul 18, 2025

10 Hot Penny Stocks to Invest in Now - Insider Monkey

Jul 18, 2025

Jul 16, 2025

Mizuho Securities Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Raises Target Price to $5 - 富途牛牛

Jul 16, 2025

Jul 16, 2025

Mizuho raises Neumora Therapeutics stock price target on new drug candidate - Investing.com Canada

Jul 16, 2025

Jul 15, 2025

Why Neumora Therapeutics Inc. stock attracts strong analyst attentionSolid Return Trade Selections - Newser

Jul 15, 2025

Jul 15, 2025

How Neumora Therapeutics Inc. stock performs during market volatilityCarefully Curated High Return Stocks - Newser

Jul 15, 2025

Jul 15, 2025

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Solid Biosciences (SLDB) and Belite Bio, Inc. ADR (BLTE) - The Globe and Mail

Jul 15, 2025

Jul 12, 2025

FibroBiologics (NASDAQ:FBLG) vs. Neumora Therapeutics (NASDAQ:NMRA) Head to Head Contrast - Defense World

Jul 12, 2025

Jul 11, 2025

Neumora Therapeutics (NMRA) Soars 33.02% on Drug Trial Advancement - AInvest

Jul 11, 2025

Jul 11, 2025

H.C. Wainwright reiterates Buy rating on Neumora Therapeutics stock By Investing.com - Investing.com Canada

Jul 11, 2025

Jul 10, 2025

Neumora begins phase 1 trial of schizophrenia drug NMRA-861 By Investing.com - Investing.com South Africa

Jul 10, 2025

Jul 09, 2025

Neumora Therapeutics’ Promising M4 PAM Program Drives Buy Rating with $18 Price Target - TipRanks

Jul 09, 2025

Jul 09, 2025

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861 - The Manila Times

Jul 09, 2025